Immune Pharmaceuticals, Weizmann Institute of Science deal

Immune partnered with Yeda Research and Development Company Ltd., the institute's technology transfer arm, to develop antibodies against epidermal growth factor receptor 3 ( EGFR3; HER3; ErbB3) for...